Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
7,113 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05862792 | Liposomal Bupivacaine and Transoral Robotic Surgery | recruiting | — | 80 | Geisinger ClinicOTHER | 1 | Sep 9, 2025 | clinicaltrials |
| NCT06187402 | A Study of LM-24C5 For Advanced Solid Tumors | recruiting | Phase 1 / Phase 2 | 49 | LaNova Medicines LimitedINDUSTRY | 1 | Sep 9, 2025 | clinicaltrials |
| NCT06535139 |
| ReMARK: Addressing Disparities in Rural HPV-related Cancer Prevention |
| recruiting |
| N/A |
| 4,630 |
| University of FloridaOTHER |
| 1 |
| Sep 9, 2025 |
| clinicaltrials |
| NCT06682793 | A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression(DENALI-1) | recruiting | Phase 1 / Phase 2 | 240 | A2 Biotherapeutics Inc.INDUSTRY | 1 | Sep 9, 2025 | clinicaltrials |
| NCT06815354 | Comprehensive Assessment of Cancer Theranostic Response(TRAQinform) | recruiting | N/A | 32 | AIQ SolutionsINDUSTRY | 1 | Sep 9, 2025 | clinicaltrials |
| NCT06262321 | Thoracic Radiotherapy for Patients With Metastatic (Stage IV) Non-Small Cell Lung Cancer at High Risk of Symptomatic Progression Within the Thorax(DRO2301) | recruiting | Phase 2 | 48 | University of RochesterOTHER | 1 | Sep 8, 2025 | clinicaltrials |
| NCT06868485 | A Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung Cancer | recruiting | Phase 2 | 40 | Wayshine Biopharm, Inc.INDUSTRY | 3 | Sep 8, 2025 | clinicaltrials |
| NCT07158723 | Protein and Polycystic Ovary Syndrome (PCOS) | recruiting | N/A | 60 | University of Arkansas, FayettevilleOTHER | 1 | Sep 8, 2025 | clinicaltrials |
| NCT07158918 | ABL103 in Combination With Pembrolizumab, With or Without Taxane in Advanced or Metastatic Solid Tumors | recruiting | Phase 1 / Phase 2 | 65 | ABL Bio, Inc.INDUSTRY | 3 | Sep 8, 2025 | clinicaltrials |
| NCT07160296 | Supporting Treatment Resilience With Optimized Nutrition and Guided Exercise in Head and Neck Cancer Patients Undergoing Chemoradiation(STRONGER) | recruiting | N/A | 30 | Renown HealthOTHER | 1 | Sep 8, 2025 | clinicaltrials |
| NCT05372354 | A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma | recruiting | Phase 1 / Phase 2 | 260 | Bristol-Myers SquibbINDUSTRY | 5 | Sep 5, 2025 | clinicaltrials |
| NCT05932862 | A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors | recruiting | Phase 1 | 429 | ExelixisINDUSTRY | 1 | Sep 5, 2025 | clinicaltrials |
| NCT06015022 | EGCG for Hepatocellular Carcinoma Chemoprevention(CATCH-B) | recruiting | Phase 2 | 60 | University of Texas Southwestern Medical CenterOTHER | 1 | Sep 5, 2025 | clinicaltrials |
| NCT06262516 | Nephroureterectomy With and Without Lymph Node Dissection for Upper Tract Urothelial Cell Carcinoma | recruiting | N/A | 94 | Case Comprehensive Cancer CenterOTHER | 1 | Sep 5, 2025 | clinicaltrials |
| NCT04098146 | Registry to Collect Data on Patients Undergoing Segmental Mandibular Defect Reconstruction Following Oral Squamous Cell Carcinoma Resection and Drugs-induced Osteonecrosis | recruiting | — | 300 | AO Innovation Translation CenterOTHER | 8 | Sep 4, 2025 | clinicaltrials |
| NCT07153614 | Efficacy of Perioperative Opioid Sparing Techniques on Time to Initiation of Chemotherapy | recruiting | N/A | 200 | University of Tennessee Graduate School of MedicineOTHER | 1 | Sep 4, 2025 | clinicaltrials |
| NCT04860453 | Genomic Analysis of Families With a History of Discordant Cancers | recruiting | — | 150 | Case Comprehensive Cancer CenterOTHER | 1 | Sep 3, 2025 | clinicaltrials |
| NCT06313359 | Fall Risk and Quality of Life: in Individuals With Cancer Treatment Related Peripheral Neuropathy. | recruiting | — | 40 | Texas Woman's UniversityOTHER | 1 | Sep 3, 2025 | clinicaltrials |
| NCT06382168 | DFP-10917 in Combination With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia | recruiting | Phase 1 / Phase 2 | 39 | Delta-Fly Pharma, Inc.INDUSTRY | 1 | Sep 3, 2025 | clinicaltrials |
| NCT06571708 | Gemcitabine/Cisplatin Plus Cemiplimab With or Without Fianlimab in Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT)(NeoSTOP-IT) | recruiting | Phase 2 | 36 | Columbia UniversityOTHER | 1 | Sep 2, 2025 | clinicaltrials |
| NCT07142603 | Appetite Response to Meals With Different Protein Sources in Women With PCOS | recruiting | N/A | 30 | University of Arkansas, FayettevilleOTHER | 1 | Sep 2, 2025 | clinicaltrials |
| NCT06541990 | Psychoeducational Intervention for Patients With Hepatocellular Carcinoma(HARMONY) | recruiting | N/A | 50 | Massachusetts General HospitalOTHER | 1 | Aug 29, 2025 | clinicaltrials |
| NCT03878849 | Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian Cancer | recruiting | Phase 2 | 40 | Allarity TherapeuticsINDUSTRY | 1 | Aug 28, 2025 | clinicaltrials |
| NCT05130606 | CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing | recruiting | N/A | 332 | Georgetown UniversityOTHER | 1 | Aug 28, 2025 | clinicaltrials |
| NCT07145411 | HPC Offered for PRESERVE Expansion(HOPE) | recruiting | — | 10 | Ossium Health, Inc.INDUSTRY | 1 | Aug 28, 2025 | clinicaltrials |
| NCT04863950 | Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma | recruiting | Phase 2 | 25 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Aug 27, 2025 | clinicaltrials |
| NCT06134232 | Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T(ProvONE) | recruiting | Phase 2 | 400 | DendreonINDUSTRY | 1 | Aug 27, 2025 | clinicaltrials |
| NCT06887218 | 5-Fluorouracil/Leucovorin (5FU/LV) in Combination With Regorafenib in Patients With Metastatic Colorectal Cancer | recruiting | Phase 2 | 57 | The Methodist Hospital Research InstituteOTHER | 1 | Aug 27, 2025 | clinicaltrials |
| NCT03850574 | Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia(TUSCANY) | recruiting | Phase 1 / Phase 2 | 240 | Aptose Biosciences Inc.INDUSTRY | 6 | Aug 26, 2025 | clinicaltrials |
| NCT06908629 | Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors | recruiting | N/A | 120 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Aug 26, 2025 | clinicaltrials |
| NCT07142408 | The Effect of Bacterial Decolonization Before Skin Cancer Surgery on Infection Rate of Lower Extremity Wounds Left Open to Heal | recruiting | Phase 3 | 848 | The Cooper Health SystemOTHER | 1 | Aug 26, 2025 | clinicaltrials |
| NCT03954431 | High-Resolution Lower Dose Dedicated Breast Computed Tomography (CT)(LowerDoseBCT) | recruiting | N/A | 600 | University of ArizonaOTHER | 1 | Aug 24, 2025 | clinicaltrials |
| NCT05607420 | Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma(NatHaLi-01) | recruiting | Phase 1 / Phase 2 | 80 | Cellectis S.A.INDUSTRY | 3 | Aug 24, 2025 | clinicaltrials |
| NCT06867822 | Trial of ProAgio in Advanced/Metastatic Colorectal Cancer | recruiting | Phase 1 | 27 | University of Alabama at BirminghamOTHER | 1 | Aug 24, 2025 | clinicaltrials |
| NCT03492151 | Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions(CLIMB) | recruiting | — | 500 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Aug 22, 2025 | clinicaltrials |
| NCT05217940 | Screening Women With Prior HPV for Anal Neoplasia(SWAN) | recruiting | N/A | 300 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Aug 22, 2025 | clinicaltrials |
| NCT05113368 | Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer | recruiting | Phase 2 | 31 | Sarah K. Lynam MDOTHER | 1 | Aug 21, 2025 | clinicaltrials |
| NCT03053193 | MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles(FLEX) | recruiting | — | 30,000 | AgendiaINDUSTRY | 4 | Aug 20, 2025 | clinicaltrials |
| NCT05739123 | Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring | recruiting | — | 728 | Sumitomo Pharma Switzerland GmbHINDUSTRY | 1 | Aug 19, 2025 | clinicaltrials |
| NCT06907043 | A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.(EIK1004-001) | recruiting | Phase 1 / Phase 2 | 130 | Eikon TherapeuticsINDUSTRY | 3 | Aug 19, 2025 | clinicaltrials |
| NCT07130708 | Exploring the Potential of Robotic Telesurgery in Remote Settings | recruiting | N/A | 10 | AdventHealthOTHER | 1 | Aug 19, 2025 | clinicaltrials |
| NCT05394103 | Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors | recruiting | Phase 1 / Phase 2 | 130 | Qurient Co., Ltd.INDUSTRY | 2 | Aug 17, 2025 | clinicaltrials |
| NCT05725291 | AMT-116 in Patients With Advanced Solid Tumors | recruiting | Phase 1 | 80 | Multitude Therapeutics Inc.INDUSTRY | 3 | Aug 17, 2025 | clinicaltrials |
| NCT05761223 | A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849 | recruiting | Phase 1 / Phase 2 | 151 | 1ST Biotherapeutics, Inc.INDUSTRY | 1 | Aug 17, 2025 | clinicaltrials |
| NCT05802069 | MCW Master Predict (Profile Related Evidence Determining Individualized Cancer Therapy) | recruiting | — | 10,000 | Sameem M. Abedin, MDOTHER | 1 | Aug 17, 2025 | clinicaltrials |
| NCT06907615 | A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC) | recruiting | Phase 2 | 243 | Shanghai Henlius BiotechINDUSTRY | 2 | Aug 17, 2025 | clinicaltrials |
| NCT04429542 | Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors | recruiting | Phase 1 | 292 | Bicara TherapeuticsINDUSTRY | 3 | Aug 15, 2025 | clinicaltrials |
| NCT05049837 | PROSPECT - Profiling of Resistance Patterns & Oncogenic Signaling Pathways in Evaluation of Cancers of the Thorax and Therapeutic Target Identification | recruiting | — | 7,200 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 15, 2025 | clinicaltrials |
| NCT05406167 | Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System(PREMIER) | recruiting | — | 500 | RefleXion MedicalINDUSTRY | 1 | Aug 15, 2025 | clinicaltrials |
| NCT04442724 | Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy(FMBRT) | recruiting | N/A | 60 | Cedars-Sinai Medical CenterOTHER | 1 | Aug 14, 2025 | clinicaltrials |
Data updated 24 days agoSource updated unknownsource: clinicaltrials